Monitoring of 30 marker candidates in early Parkinson disease as progression markers. - Wikidata - wikimedia - TriplyDB

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

http://www.wikidata.org/entity/Q30783504

about

Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects Candidate inflammatory biomarkers display unique relationships with alpha-synuclein and correlate with measures of disease severity in subjects with Parkinson's disease.The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.Cognitive decline in Parkinson disease.Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson's disease: a meta and meta-regression analysis.REM Sleep Behavior Disorder in Parkinson's Disease and Other Synucleinopathies.Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease.The Evolution of REM Sleep Behavior Disorder in Early Parkinson Disease.The depressed brain in Parkinson's disease: Implications for an inflammatory biomarker.Distinct metabolomic signature in cerebrospinal fluid in early parkinson's disease.Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Idiopathic REM sleep behaviour disorder and neurodegeneration - an update.Premotor Diagnosis of Parkinson's Disease.Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts.The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease.Characterization of Dopaminergic System in the Striatum of Young Adult Park2-/- Knockout Rats.Advanced Parkinson's or "complex phase" Parkinson's disease? Re-evaluation is needed.Accuracy of Rating Scales and Clinical Measures for Screening of Rapid Eye Movement Sleep Behavior Disorder and for Predicting Conversion to Parkinson's Disease and Other Synucleinopathies.Mild Cognitive Impairment in Parkinson's Disease-What Is It?Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?The Luxembourg Parkinson's Study: A Comprehensive Approach for Stratification and Early Diagnosis

P2860

Q33734084-A60A0547-7DF7-4B62-AA0D-DAB6BD0C6B6A Q38556918-ABC44762-F589-45CA-88FA-A983A75ED416 Q38607424-AB18A05C-48EA-4B16-B09A-A85126E17924 Q38751099-63AA371B-09A9-497C-B1FE-4003C9F73F22 Q39149219-BF928175-85F4-4474-B374-E9246113E646 Q39259862-18D6D23A-1BA2-4D88-91F6-B52FF3C10AFB Q39312598-99CF4A60-DC9A-477D-9B0D-E212926A5FED Q39366291-5616CE3A-F118-4A66-BAFD-4D6B0921DD33 Q39681041-A0ABC136-5235-42E0-9819-D5EACD1E6397 Q41709984-395E371D-9BB7-4DAF-A93E-284FC3B77BD1 Q45946065-5AEDBE78-85DD-4258-B4A6-E40794383DB5 Q46012657-FF728698-B55B-41E9-ABB1-2FA219F25D6B Q46965498-888DC8F2-37AB-4942-8542-A040BEBC60E8 Q47338262-0DFF232E-EA24-4CC6-B25B-B53CF69E1B55 Q47660301-810A9CD1-F26A-4163-8C6F-CBEDAAC2FD3B Q47701138-CA7E96A3-C909-43D0-9E42-263ADBFBD1E0 Q47730775-3154932E-6085-4C53-8802-ED79BC3F2E01 Q47739964-C15FFF55-1042-4172-B6A4-A7E1197B261A Q48171776-E28C809E-730E-4FA1-95A8-8CB6BAAD34E5 Q50108912-7FA27F62-42BC-4850-A84D-AC85E79B6A1C Q55339951-1DE3AD9A-8531-4763-B942-FFD326E49E4E Q55387790-538465F0-C6AB-46FC-933E-65F1D97210E2 Q58585963-1E78A9AE-3E7D-478F-AFBD-CF87E05F36DE Q58699032-2611AB4F-0EA3-4B6F-9D35-6F65AE673053

P2860

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

http://www.wikidata.org/entity/Q30783504

description

2016 nî lūn-bûn

@nan

2016 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@ast

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@en

type

label

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@ast

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@en

prefLabel

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@ast

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@en

P1433

Q30783504-01360AD4-8C95-41A4-936D-152EA170DC07

P1476

Q30783504-D0ED5B10-9B30-4880-BB50-B8B80B941457

P2093

Q30783504-2EF855C4-AFFD-487F-A4E7-D5618D5A96F3

Q30783504-4253A26C-D5A0-42FC-9442-69FF27AF2AD5

Q30783504-5CA7DC8B-56DB-4431-AF59-21184F4F34FE

Q30783504-B2D5B920-9F35-4F1B-9E35-0BA1DE41D70C

Q30783504-D48F1AC1-1FE3-4004-8B54-25CEE7D797F2

Q30783504-DA6C9E5E-74CB-4F9D-9AC8-DD6FA089DC64

Q30783504-DFAE92F5-9426-4928-B7E1-147E7A6B5C81

Q30783504-ECAEADAB-58A8-41B2-B3F4-24A9D1A9399E

P2860

Q30783504-095E9B7A-3688-4D07-BD42-FDB34A422ED5

Q30783504-116F3759-7BA3-4DB2-8518-23006F61AEB6

Q30783504-1D8244D2-07E2-4738-836A-9141F7AEF102

Q30783504-2264CADD-D579-4D22-A49A-84A452CDE08E

Q30783504-23DF5C14-EBB8-4A53-A1AF-AC7E99F8E745

Q30783504-24BEE5F9-85DA-4196-B223-49A3EDF10530

Q30783504-33DEC150-810C-4CF3-B9A8-F945D12AF05B

Q30783504-398C97C7-3487-4B7D-B415-504C665059A3

Q30783504-3B1B4AD5-2D5F-44D4-9C41-CE3C01AF2060

Q30783504-4DC33F33-E828-446A-92D5-759B090F3287

P304

Q30783504-B7A453C3-C689-4BE5-9DDA-BF163DF387A1

P31

Q30783504-389D9978-2F93-402A-8D91-3FEAF5C6D286

P356

Q30783504-F9FF8A34-BFF8-4B25-94C8-AFF9FBE6AF54

P407

Q30783504-41DA2279-6F81-4BDE-AC7F-3D31C440F8F0

P433

Q30783504-9E13F7C7-65B5-42A1-9315-6FB9111B8BFB

P478

Q30783504-464DB37E-217A-469B-99EC-8D6E39383D2A

P50

Q30783504-041A7D9C-F7A5-42DF-86DA-5042FADD170C

Q30783504-05D98467-56BC-4F37-B108-15D14726E67A

Q30783504-265C32FB-BBD4-445C-B61F-B6E614FA2C61

Q30783504-4A81C466-252E-4EB4-AA3E-4FC19F4D5865

Q30783504-C36E7123-1EA1-4AB8-8F5C-6EB043194CB6

Q30783504-D3ED72CE-7674-4103-B934-79532CD43466

P577

Q30783504-637CEFC0-6875-4CE6-972B-E5B9896100D7

P698

Q30783504-507E0C4E-A744-4D2C-B339-F8C92EB9A742

P921

Q30783504-DD3DC99B-9022-4C97-B1B5-D48342698C8D

P932

Q30783504-B8225AD6-AF6C-4BF9-8670-15C92DF7A16C

P356

WNL.0000000000002651

P1433

P1476

Monitoring of 30 marker candidates in early Parkinson disease as progression markers.

@en

P2093

DeNoPa Study Group

http://www.w3.org/2001/XMLSchema#string

Elisabeth Lang

http://www.w3.org/2001/XMLSchema#string

Ellen Trautmann

http://www.w3.org/2001/XMLSchema#string

Jens Ebentheuer

http://www.w3.org/2001/XMLSchema#string

Martina Schaumburg

http://www.w3.org/2001/XMLSchema#string

Niels K Focke

http://www.w3.org/2001/XMLSchema#string

Peggy Taylor

http://www.w3.org/2001/XMLSchema#string

Tamara Wicke

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

No adjustments are needed for multiple comparisons

Cerebrospinal fluid α-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort.

Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer's disease.

Urate as a predictor of the rate of clinical decline in Parkinson disease.

The Parkinson Progression Marker Initiative (PPMI).

Predictors of dementia in Parkinson disease: a prospective cohort study.

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease.

Intraindividual variability of REM sleep behavior disorder in Parkinson's disease: a comparative assessment using a new REM sleep behavior disorder severity scale (RBDSS) for clinical routine.

Surrogate endpoints in Parkinson's disease research.

P304

168-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000002651

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

Brit Mollenhauer

Claudia Trenkwalder

Friederike Sixel-Döring

Johannes Zimmermann

Henrik Zetterberg

P577

2016-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27164658

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4940068

http://www.w3.org/2001/XMLSchema#string